KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $1.51.

  • Incyte's EPS (Basic) rose 5729.17% to $1.51 in Q4 2025 from the same period last year, while for Dec 2025 it was $6.59, marking a year-over-year increase of 276521.74%. This contributed to the annual value of $6.59 for FY2025, which is 401875.0% up from last year.
  • Per Incyte's latest filing, its EPS (Basic) stood at $1.51 for Q4 2025, which was up 5729.17% from $2.17 recorded in Q3 2025.
  • Incyte's 5-year EPS (Basic) high stood at $2.55 for Q4 2021, and its period low was -$2.04 during Q2 2024.
  • Its 5-year average for EPS (Basic) is $0.77, with a median of $0.76 in 2023.
  • In the last 5 years, Incyte's EPS (Basic) surged by 127142.86% in 2021 and then tumbled by 32417.58% in 2024.
  • Incyte's EPS (Basic) (Quarter) stood at $2.55 in 2021, then plummeted by 95.29% to $0.12 in 2022, then soared by 650.0% to $0.9 in 2023, then rose by 6.67% to $0.96 in 2024, then skyrocketed by 57.29% to $1.51 in 2025.
  • Its EPS (Basic) was $1.51 in Q4 2025, compared to $2.17 in Q3 2025 and $2.09 in Q2 2025.